Artikel (Klinikum der LMU)

Boukovala, M.; Modest, D.P.; Ricard, I.; Fischer von Weikersthal, L.; Decker, T.; Vehling-Kaiser, U.; Uhlig, J.; Schenk, M.; Freiberg-Richter, J.; Peuser, B.; Denzlinger, C.; Peveling Genannt Reddemann, C.; Graeven, U.; Schuch, G.; Schwaner, I.; Heinrich, K.; Neumann, J.; Jung, A.; Held, S.; Stintzing, S.; Heinemann, V.; Michl, M. (2024): Evaluation of the inflammation-based modified Glasgow Prognostic Score (mGPS) as a prognostic and predictive biomarker in patients with metastatic colorectal cancer receiving first-line chemotherapy: a post hoc analysis of the randomized phase III XELAVIRI trial (AIO KRK0110). ESMO Open, 9 (5): 103374. ISSN 20597029